Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News May 6 2021 | FARXIGA approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type 2 diabetes Industry News Industry Read More Mar 24 2021 | U.S. Food and Drug Administration (FDA) Accepts Bristol Myers Squibb’s Application for Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Industry News In The News Industry Read More Feb 19 2021 | Novartis Entresto® granted expanded indication in chronic heart failure by FDA Industry News Industry Read More Jan 22 2021 | Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) Industry News Industry Read More Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page Next › Last page Last »
May 6 2021 | FARXIGA approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type 2 diabetes Industry News Industry Read More
Mar 24 2021 | U.S. Food and Drug Administration (FDA) Accepts Bristol Myers Squibb’s Application for Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Industry News In The News Industry Read More
Feb 19 2021 | Novartis Entresto® granted expanded indication in chronic heart failure by FDA Industry News Industry Read More
Jan 22 2021 | Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) Industry News Industry Read More
Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More
